Overview
Tetsuya Minegaki practices in Kyoto, Japan. Mr. Minegaki is rated as an Advanced expert by MediFind in the treatment of Rhabdomyolysis. His top areas of expertise are Rhabdomyolysis, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and Esophageal Cancer.
His clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Rhabdomyolysis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RhabdomyolysisMr. Minegaki isAdvanced. Learn about Rhabdomyolysis.
- Experienced
- Chronic Kidney DiseaseMr. Minegaki isExperienced. Learn about Chronic Kidney Disease.
- End-Stage Renal Disease (ESRD)Mr. Minegaki isExperienced. Learn about End-Stage Renal Disease (ESRD).
- Esophageal CancerMr. Minegaki isExperienced. Learn about Esophageal Cancer.
- RhabdomyosarcomaMr. Minegaki isExperienced. Learn about Rhabdomyosarcoma.